| Período | Preço Previsto | Passado | Histórico | Comentário |
|---|---|---|---|---|
| Amanhã | $0.6348 ▼ -0.80% | Ontem | $0.6420 ▲ +0.33% | Tomorrow's VYNE Therapeutics Inc. Common Stock (VYNE) setup is anchored to $0.6399 and targets $0.6348 (-0.80%). The near-term read is downside; watch $0.6591 / $0.6207 because daily realized volatility is about 4.10%. |
Tomorrow's VYNE Therapeutics Inc. Common Stock (VYNE) setup is anchored to $0.6399 and targets $0.6348 (-0.80%). The near-term read is downside; watch $0.6591 / $0.6207 because daily realized volatility is about 4.10%. | ||||
| Semana | $0.6241 ▼ -2.48% | Semana Passada | $0.6466 ▲ +1.04% | The 7-day VYNE Therapeutics Inc. Common Stock model moves from $0.6466 to $0.6241 (-2.48%). It gives downside momentum context for this stock, so breaks around $0.6591 / $0.6207 matter more than a single tick. |
The 7-day VYNE Therapeutics Inc. Common Stock model moves from $0.6466 to $0.6241 (-2.48%). It gives downside momentum context for this stock, so breaks around $0.6591 / $0.6207 matter more than a single tick. | ||||
| Mês | $0.6062 ▼ -5.27% | Mês Passado | $0.6541 ▲ +2.21% | The 1-month VYNE Therapeutics Inc. Common Stock target is $0.6062 (-5.27%), compared with the live reference near $0.6399. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month VYNE Therapeutics Inc. Common Stock target is $0.6062 (-5.27%), compared with the live reference near $0.6399. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Ano | $0.5793 ▼ -9.46% | Ano Passado | $0.6653 ▲ +3.97% | The 1-year VYNE Therapeutics Inc. Common Stock scenario points to $0.5793 (-9.46%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year VYNE Therapeutics Inc. Common Stock scenario points to $0.5793 (-9.46%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Anos | $0.5165 ▼ -19.29% | Há 5 Anos | $0.6917 ▲ +8.10% | The 5-year VYNE Therapeutics Inc. Common Stock view is $0.5165 (-19.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year VYNE Therapeutics Inc. Common Stock view is $0.5165 (-19.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicador | Valor | Sinal |
|---|---|---|
| Price | $0.6399 | Mid |
| Daily Change | +1.06% | Above |
| Volatility Cap | 20.0% | Mid |
| Confidence | 59% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $0.6399 | Daily Change | +1.06% |
| Market Cap | $21.32M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.